Understand the route before choosing care.
Decision points
Bring this list to an online or in-person visit. Clear answers matter more than a polished sales page.
Bring these
Who will evaluate me, and where can I verify that person’s license?
Will the visit allow follow-up questions?
What exact medicine is being considered, and is it a pill, a shot, or something else?
Has the FDA approved that exact product, is it made to order by a pharmacy, or is it unapproved?
Which pharmacy makes it, and may I fill the prescription elsewhere?
What is known, what is not known, and what is the full cost?
The visit itself
As of September 2026, the North Carolina Medical Board says a fixed online form on its own is not enough for diagnosis or prescribing.
The clinician needs a way to ask more questions or gather more history.
In North Carolina, an online visit has to meet the bar an office visit would. The clinician should tell you their name, where they work, and their qualifications, and should send you to be seen in person when you need an exam or a test. If the clinician cannot learn enough about you online to treat you safely, the board says online care is not right for that case.
Source: North Carolina Medical Board telemedicine statement.
Check the records
As of September 2026, these state board searches are the official places to check those license records. A listed record does not rate the quality of care.
If compounding comes up
A compounded medicine is mixed for one patient instead of coming off a shelf ready-made.
Compounded medicines, as of September 2026, carry no FDA approval, and nobody at the FDA vets them for safety, effectiveness, or quality ahead of sale.
The next useful question is simple: “Which pharmacy actually makes and sends this?” Then check that name with the pharmacy board.
As of September 2026, a service offering prescription-only medicine without a prescription is a stop sign.